Tenosal

This classification denotes a calcium channel blocker with the molecular formula C12H8O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EEK88K197T, chemically known as 2-thiophenecarboxylic acid, ester with salicylic acid but generally known as tenosal, which bears US NIH Compound Identifier 65838. European Medicines Agency schedules Tenosal in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10898MIG. The term TENOSAL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). TENOSAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tenosal under HS 29349990 and SITC 51579. As of Q4 2014, TENOSAL remains the US FDA Preferred Term for this commodity. Tenosal bears US NLM identifiers UMLS ID C2699913 and NCI Concept Code C76584. SMILES: s1c(C(=O)Oc2c(cccc2)C(=O)O)ccc1.